Revvity, Inc. provides health science solutions, technologies, expertise, and services that deliver complete workflows from discovery to development, and diagnosis to cure. The company is headquartered in Waltham, Massachusetts and currently employs 11,000 full-time employees. The firm has specialized focus areas in translational multi-omics technologies, biomarker identification, imaging, prediction, screening, detection and diagnosis, informatics and more. Its segments include Life Sciences and Diagnostics. The Life Sciences segment provides products and services targeted towards the life sciences market. The segment offers instruments, reagents, software, detection and imaging technologies, and others. The Diagnostics segment develops diagnostics, tools, and applications focused on clinically oriented customers, within the reproductive health, immunodiagnostics, and applied genomics markets. The segment offers instruments, reagents, assay platforms and software to hospitals, medical labs, clinicians and medical research professionals to help improve the health of families.
Dr. Prahlad Singh est le President de Revvity Inc, il a rejoint l'entreprise depuis 2016.
Quelle est la performance du prix de l'action RVTY ?
Le prix actuel de RVTY est de $87.7, il a augmenté de 0.27% lors de la dernière journée de trading.
Quels sont les thèmes d'affaires principaux ou les industries de Revvity Inc ?
Revvity Inc appartient à l'industrie Life Sciences Tools & Services et le secteur est Health Care
Quel est la capitalisation boursière de Revvity Inc ?
La capitalisation boursière actuelle de Revvity Inc est de $9.8B
Est-ce que Revvity Inc est un achat, une vente ou un maintien ?
Selon les analystes de Wall Street, 20 analystes ont établi des notations d'analystes pour Revvity Inc, y compris 7 achat fort, 10 achat, 8 maintien, 1 vente et 7 vente forte